Virtu Financial’s Adaptive Biotechnologies ADPT Stock Holding History

Virtu Financial’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-24,475	Closed	-$120K	–	1356
2023 Q4	$120K	Sell	24,475 -42,187	-63%	-$192K	0.01%	986
2023 Q3	$363K	Buy	66,662 +52,822	+382%	+$349K	0.04%	433
2023 Q2	$93K	Buy	+13,840	New	+$103K	0.01%	1054
2021 Q4	–	Sell	-10,202	Closed	-$347K	–	1651
2021 Q3	$347K	Buy	+10,202	New	+$369K	0.03%	640
2021 Q2	–	Sell	-14,579	Closed	-$587K	–	1450
2021 Q1	$587K	Buy	14,579 +8,118	+126%	+$439K	0.04%	447
2020 Q4	$382K	Buy	+6,461	New	+$333K	0.04%	535

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

AAP

Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return

Virtu Financial's ADPT Position: Q1 2024 in Review

Virtu Financial sold out of Adaptive Biotechnologies (ADPT) in Q1 2024, closing a stake of 24,475 shares — an estimated $120K sold.

Virtu Financial first reported a position in ADPT in Q4 2020 and held it in 6 quarters. The position peaked at $587K in Q1 2021. 190 funds tracked by Wall St. Rank hold ADPT as of Q1 2024.

Virtu Financial reported no remaining Adaptive Biotechnologies position as of Q1 2024 after selling out during the quarter.
Virtu Financial sold 24,475 Adaptive Biotechnologies shares in Q1 2024, an estimated $120K.
Virtu Financial first reported a position in Adaptive Biotechnologies in Q4 2020 and held it in 6 quarters.
Virtu Financial's Adaptive Biotechnologies position peaked at $587K in Q1 2021.
190 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2024.

Based on Virtu Financial's 13F filing for Q1 2024, filed 20 May 2024.